有效的尿石症治疗需要进行代谢分类（作者译）
[Effective treatment of urolithiasis requires metabolic classification (author's transl)].
作者信息
Scholz D, Schwille P O, Sigel A
出版信息
Urologe A. 1980 Jul;19(4):202-6.
PMID:7414764
Abstract
A diagnostic program for the metabolic classification of urolithiasis is proposed on the basis of pathophysiologic mechanisms. It allows categorization of patients in various subgroups, which is a prerequisite for the different regimens of non-surgical treatment. The characteristic clinical and biochemical features underlying this classification are outlined.
摘要
基于病理生理机制，提出了一种用于尿石症代谢分类的诊断程序。它可以将患者分类到不同的亚组中，这是不同非手术治疗方案的前提条件。本文概述了该分类背后的特征性临床和生化特征。
相似文献
1
[Effective treatment of urolithiasis requires metabolic classification (author's transl)].有效的尿石症治疗需要进行代谢分类（作者译）
Urologe A. 1980 Jul;19(4):202-6.
2
[The conservative therapy of urolithiasis (author's transl)].[尿石症的保守治疗（作者译）]
Urologe A. 1979 Jul;18(4):193-8.
3
[The value attached to clinical laboratory findings in urolithiasis (author's transl)].[尿路结石临床实验室检查结果的价值（作者译）]
Wien Klin Wochenschr. 1974 Nov 15;86(21):654-7.
4
[Grouping of urinary stones and exactness of analyses (author's transl)].尿结石的分组与分析的准确性（作者译）
Urol Int. 1976;31(3):217-9. doi: 10.1159/000280055.
5
Nutrition and urolithiasis.营养与尿石症
N Engl J Med. 1978 Jan 12;298(2):87-9. doi: 10.1056/NEJM197801122980207.
6
[Urolithiasis - a review of pathophysiology, diagnostic procedures and therapy (author's transl)].[尿石症——病理生理学、诊断方法及治疗综述（作者译）]
Wien Klin Wochenschr. 1980 Jun;92(12):411-20.
7
[Prevention of relapse in urolithiasis (author's transl)].尿石症复发的预防（作者译）
Munch Med Wochenschr. 1973 Nov 16;115(46):2079-83.
8
[Non-invasive treatment of urinary lithiasis. II. Local chemolysis].[尿石症的非侵入性治疗。II. 局部化学溶解]
Actas Urol Esp. 1985 Nov-Dec;9(6):465-8.
9
[Color tests for the qualitative determination of cystine and uric acid in urinary calculi].
Urologe A. 1972 Nov;11(6):321-3.
10
Prevention of stone disease.结石病的预防。
Urol Int. 2007;79 Suppl 1:37-46. doi: 10.1159/000104440.
引用本文的文献
1
Parathyroid gland function in subgroups of metabolically mediated urolithiasis as evaluated by serum parathyroid hormone, and urinary and nephrogenous cyclic nucleotides.
Klin Wochenschr. 1982 Mar 1;60(5):229-36. doi: 10.1007/BF01728341.
Zotero 插件